AsOf

Recorded or changed on this day 2026-11-08

2,101–2,150 of 46,540 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 34,741,000,000 United States dollar
Amgen cash and equivalents: 34,741,000,000 United States dollar, claim clm_49C1DCF00977 · ended · superseded by clm_71DDBB020158 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 4,521,000,000 United States dollar
Amgen quarterly revenue: 4,521,000,000 United States dollar, claim clm_4A26C5460842 · ended · superseded by clm_F203C4084F80 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 66,416,000,000 United States dollar
Amgen total assets: 66,416,000,000 United States dollar, claim clm_4B925E62643E · ended · superseded by clm_1431EBB4BEA3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 3,661,000,000 United States dollar
Amgen total equity: 3,661,000,000 United States dollar, claim clm_4BA44A742FE5 · ended · superseded by clm_DD0F42269A48 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 2,419,000,000 United States dollar
Amgen total equity: 2,419,000,000 United States dollar, claim clm_4BB765E7F1FC · ended · superseded by clm_2983532AC508 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 979,301,627 shares
Amgen shares outstanding: 979,301,627 shares, claim clm_4C0262AA6F8C · ended · superseded by clm_718FD5DF2CAF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 32,229,000,000 United States dollar
Amgen total equity: 32,229,000,000 United States dollar, claim clm_4C3C0E706B52 · ended · superseded by clm_C6D997322E62 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 19,060,000,000 United States dollar
Amgen total equity: 19,060,000,000 United States dollar, claim clm_4CC7E97EBEA6 · ended · superseded by clm_D045AE9FFC56 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 45,765,000,000 United States dollar
Amgen total assets: 45,765,000,000 United States dollar, claim clm_4D9D4E243B38 · ended · superseded by clm_FCCCD0433A56 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,698,000,000 United States dollar
Amgen quarterly operating income: 2,698,000,000 United States dollar, claim clm_4DB5BAF9C86F · ended · superseded by clm_A7F81572ADB3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 4,238,000,000 United States dollar
Amgen quarterly revenue: 4,238,000,000 United States dollar, claim clm_4DC2460750E0 · ended · superseded by clm_B14B41207FDF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 729,674,773 shares
Amgen shares outstanding: 729,674,773 shares, claim clm_4DCBBE171CD3 · ended · superseded by clm_A8C70ACAF4DA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 20,063,000,000 United States dollar
Amgen revenue: 20,063,000,000 United States dollar, claim clm_4F9F8554DED3 · ended · superseded by clm_6460A66923A8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 92,980,000,000 United States dollar
Amgen total assets: 92,980,000,000 United States dollar, claim clm_50E0EA85B3CF · ended · superseded by clm_FB713317C6E9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 71,576,000,000 United States dollar
Amgen total assets: 71,576,000,000 United States dollar, claim clm_5116B3B21711 · ended · superseded by clm_9006A4E3AEA7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 14,771,000,000 United States dollar
Amgen revenue: 14,771,000,000 United States dollar, claim clm_51956A4A09F8 · ended · superseded by clm_52AE9BB2B908 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 15,003,000,000 United States dollar
Amgen revenue: 15,003,000,000 United States dollar, claim clm_52AE9BB2B908 · ended · superseded by clm_B7B415A6CD44 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 8,281,000,000 United States dollar
Amgen cash and equivalents: 8,281,000,000 United States dollar, claim clm_54048E292013 · ended · superseded by clm_A7F5983DB63E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 770,768,879 shares
Amgen shares outstanding: 770,768,879 shares, claim clm_540E74003993 · ended · superseded by clm_6365725354C1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 69,009,000,000 United States dollar
Amgen total assets: 69,009,000,000 United States dollar, claim clm_554D2AE9FD76 · ended · superseded by clm_DD3641090074 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 6,717,000,000 United States dollar
Amgen net income: 6,717,000,000 United States dollar, claim clm_566AA4B9BFA3 · ended · superseded by clm_ED179BBDEBC9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,161,000,000 United States dollar
Amgen quarterly revenue: 6,161,000,000 United States dollar, claim clm_569470E5C2FB · ended · superseded by clm_CCB0903B5673 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 9,557,000,000 United States dollar
Amgen quarterly revenue: 9,557,000,000 United States dollar, claim clm_56EFD8BFD444 · ended · superseded by clm_BA3B03AF2A85 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · incorporated in · DE
Amgen incorporated in: DE, claim clm_56FF368E6750 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,795,000,000 United States dollar
Amgen cash and equivalents: 3,795,000,000 United States dollar, claim clm_5851D9252E69 · ended · superseded by clm_DE022A363AF0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,024,000,000 United States dollar
Amgen cash and equivalents: 2,024,000,000 United States dollar, claim clm_58CEE3D787CB · ended · superseded by clm_FA4F80522690 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,864,000,000 United States dollar
Amgen cash and equivalents: 2,864,000,000 United States dollar, claim clm_596A841E23FE · ended · superseded by clm_5851D9252E69 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 9,190,000,000 United States dollar
Amgen total equity: 9,190,000,000 United States dollar, claim clm_598BA8F87C16 · ended · superseded by clm_D4E836330B03 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,684,000,000 United States dollar
Amgen quarterly operating income: 2,684,000,000 United States dollar, claim clm_5A3FD4672B1E · ended · superseded by clm_EA063E4EB60A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,202,000,000 United States dollar
Amgen quarterly net income: 1,202,000,000 United States dollar, claim clm_5A82BDA9230D · ended · superseded by clm_B0E17E7BDD6B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,652,000,000 United States dollar
Amgen quarterly revenue: 6,652,000,000 United States dollar, claim clm_5A9AC839EF5A · ended · superseded by clm_481E925C620E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 19,239,000,000 United States dollar
Amgen total equity: 19,239,000,000 United States dollar, claim clm_5B76104742F7 · ended · superseded by clm_DB1DDF8CC003 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 4,319,000,000 United States dollar
Amgen quarterly revenue: 4,319,000,000 United States dollar, claim clm_5BA2730341DC · ended · superseded by clm_4DC2460750E0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 59,535,000,000 United States dollar
Amgen total assets: 59,535,000,000 United States dollar, claim clm_5C58544C5DCC · ended · superseded by clm_37D604168646 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,706,000,000 United States dollar
Amgen quarterly revenue: 3,706,000,000 United States dollar, claim clm_5C7EB0130754 · ended · superseded by clm_5FE67E316722 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 535,918,901 shares
Amgen shares outstanding: 535,918,901 shares, claim clm_5D00EFAD6C71 · ended · superseded by clm_7FEA7977C094 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 944,815,396 shares
Amgen shares outstanding: 944,815,396 shares, claim clm_5E708B99CEDB · ended · superseded by clm_2D844BCDB1A9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,500,000,000 United States dollar
Amgen quarterly operating income: 2,500,000,000 United States dollar, claim clm_5EAB20C5AA2A · ended · superseded by clm_E5A8056A8B32 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 8,470,000,000 United States dollar
Amgen operating income: 8,470,000,000 United States dollar, claim clm_5F24CA9F1236 · ended · superseded by clm_9C393580212E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,959,000,000 United States dollar
Amgen quarterly revenue: 3,959,000,000 United States dollar, claim clm_5FE67E316722 · ended · superseded by clm_296C33E5B63E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 991,000,000 United States dollar
Amgen quarterly operating income: 991,000,000 United States dollar, claim clm_603D27640F44 · ended · superseded by clm_DD998C1C3CBA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 534,901,181 shares
Amgen shares outstanding: 534,901,181 shares, claim clm_613418445F18 · ended · superseded by clm_70B9E417B378 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 9,409,000,000 United States dollar
Amgen total equity: 9,409,000,000 United States dollar, claim clm_6140719BE0F5 · ended · superseded by clm_38D0C83AFC61 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,804,000,000 United States dollar
Amgen quarterly revenue: 3,804,000,000 United States dollar, claim clm_623DCF66B2AC · ended · superseded by clm_1E3DCB2075FA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 19,841,000,000 United States dollar
Amgen total equity: 19,841,000,000 United States dollar, claim clm_624B06744974 · ended · superseded by clm_8B4D216D886A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 59,773,000,000 United States dollar
Amgen total assets: 59,773,000,000 United States dollar, claim clm_627ADC7F9C5A · ended · superseded by clm_BD51A9765CB0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 4,144,000,000 United States dollar
Amgen cash and equivalents: 4,144,000,000 United States dollar, claim clm_62DBA6442A89 · ended · superseded by clm_AC822552ABB6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 65,011,000,000 United States dollar
Amgen total assets: 65,011,000,000 United States dollar, claim clm_62DDE4D8FE1C · ended · superseded by clm_D6F0A4676DE8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 743,922,473 shares
Amgen shares outstanding: 743,922,473 shares, claim clm_632362E81884 · ended · superseded by clm_7DBD3E835AB8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,011,000,000 United States dollar
Amgen cash and equivalents: 9,011,000,000 United States dollar, claim clm_635D97E40729 · ended · superseded by clm_B08ED03B8CC3 · 1 source (1 primary) · conf 0.95

What the statuses mean